UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

UBC - February 08, 2013
The third annual Summit for Clinical Operations Executives (SCOPE) kicked off in Miami, Florida, this week, and UBC came asking the tough questions and proposing innovative strategies. Abbe Steel, VP of Patient and Physician Services...
Heather Gagnier, MT(ASCP), Executive Director, Commercial Strategy & Opportunity Development - February 01, 2013
As the sixth year of the REMS era begins, FDA’s use of Risk Evaluation and Mitigation Strategies (REMS) continues to decline.  Since 2007 when the FDA Amendments Act (FDAAA) went into effect, there have been more than 200 REMS...
UBC - January 29, 2013
Join us at the Cambridge Healthtech Institute's (CHI) Summit for Clinical Ops Executives (SCOPE) 2013.  UBC speakers will present perspectives and research on the latest recruitment and retention topics driving clinical...
UBC - January 23, 2013
At this week's exl Risk Evaluation & Mitigation Strategies Summit, UBC's Heather Gagnier and Lee Ann Steadman will present, Balancing Regulatory and Commercial Requirements in Complex REMS Programs.  Complex REMS,...
, Vice President, Global Pharmaceutical Business Development - January 15, 2013
It’s time we talked about how much revenue is lost due to the increasing trend in medication non-adherence.  Medication non-adherence results in an average per-drug loss of 36%, and gaining new patients costs pharma an average of...

Pages